Short Interest in Fortress Biotech, Inc. (NASDAQ:FBIOP) Increases By 1,056.5%

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 26,600 shares, a growth of 1,056.5% from the November 30th total of 2,300 shares. Based on an average daily volume of 18,600 shares, the days-to-cover ratio is currently 1.4 days.

Fortress Biotech Stock Down 3.6 %

FBIOP stock traded down $0.24 on Thursday, hitting $6.36. 12,140 shares of the company’s stock traded hands, compared to its average volume of 17,460. Fortress Biotech has a 1-year low of $4.86 and a 1-year high of $18.00. The stock has a fifty day moving average of $5.92 and a 200-day moving average of $7.70.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.